Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 10, Issue 3, 2011, Pages 193-200

  Kerem, Eitan ^a   Wilschanski, Michael ^a   Miller, Nilsen L ^b   Pugatsch, Thea ^a   Cohen, Tali ^a   Blau, Hannah ^c   Rivlin, Joseph ^d   Shoseyov, David ^a   Reha, Allen ^b   Constantine, Scott ^b   Ajayi, Temitayo ^b   Hirawat, Samit ^b   Elfring, Gary L ^b   Peltz, Stuart W ^b   Miller, Langdon L ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b PTC THERAPEUTICS   (United States)

^c SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

Adult; Cough; Cystic fibrosis; Respiratory function tests

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTICLE; CLINICAL ARTICLE; COUGHING; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE;

ADULT; COUGH; CYSTIC FIBROSIS; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT COMPLIANCE; SLEEP; TIME FACTORS; WAKEFULNESS; YOUNG ADULT;

EID: 79955958154     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.02.003     Document Type: Article

References (33)

1. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373(9678):1891-1904.
2. Mayer-Hamblett N., Aitken M.L., Accurso F.J., Kronmal R.A., Konstan M.W., Burns J.L., et al. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med 2007, 175(8):822-828.
3. Corey M. Power considerations for studies of lung function in cystic fibrosis. Proc Am Thorac Soc 2007, 4(4):334-337.
4. VanDevanter D.R., Rasouliyan L., Murphy T.M., Morgan W.J., Ren C.L., Konstan M.W., et al. Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. Pediatr Pulmonol 2008, 43(8):739-744.
5. Saiman L., Marshall B.C., Mayer-Hamblett N., Burns J.L., Quittner A.L., Cibene D.A., et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003, 290(13):1749-1756.
6. de Jong P.A., Nakano Y., Lequin M.H., Mayo J.R., Woods R., Paré P.D., et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004 Jan, 23(1):93-97.
7. Vernon M., Leidy N.K., Nacson A., Nelsen L. Measuring cough severity: Perspectives from the literature and from patients with chronic cough. Cough 2009, 5:5.
8. Sawicki G.S., Sellers D.E., Robinson W.M. Self-reported physical and psychological symptom burden in adults with cystic fibrosis. J Pain Symptom Manage 2008, 35(4):372-380.
9. Goss C.H., Quittner A.L. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007, 4(4):378-386.
10. Smith J., Woodcock A. New developments in the objective assessment of cough. Lung 2008, 186(Suppl. 1):S48-S54.
11. Irwin R.S. Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(Suppl. 1):232S-237S.
12. Morice A.H., Fontana G.A., Belvisi M.G., Birring S.S., Chung K.F., Dicpinigaitis P.V., et al. ERS guidelines on the assessment of cough. Eur Respir J 2007, 29(6):1256-1276.
13. Decalmer S.C., Webster D., Kelsall A.A., McGuinness K., Woodcock A.A., Smith J.A. Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring?. Thorax 2007, 62(4):329-334.
14. Coyle M.A., Keenan D.B., Henderson L.S., Watkins M.L., Haumann B.K., Mayleben D.W., et al. Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease. Cough 2005, 1:3.
15. Kerem E., Hirawat S., Armoni S., Yaakov Y., Shoseyov D., Cohen M., et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008, 372(9640):719-727.
16. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 153(2):S4-S14.
17. Knudson R.J., Slatin R.C., Lebowitz M.D., Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976, 113(5):587-600.
18. Hsu J.Y., Stone R.A., Logan-Sinclair R.B., Worsdell M., Busst C.M., Chung K.F. Coughing frequency in patients with persistent cough: assessment using a 24-hour ambulatory recorder. Eur Respir J 1994, 7(7):1246-1253.
19. LeGrys V.A., Yankaskas J.R., Quittell L.M., Marshall B.C., Mogayzel P.J. Cystic Fibrosis Foundation. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 2007, 151(1):85-89.
20. Wilschanski M., Famini H., Strauss-Liviatan N., Rivlin J., Blau H., Bibi H., et al. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J 2001, 17(6):1208-1215.
21. Munyard P., Bush A. How much coughing is normal?. Arch Dis Child 1996, 74(6):531-534.
22. Hamutcu R., Francis J., Karakoc F., Bush A. Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol 2002, 34(5):331-335.
23. Smith J.A., Owen E.C., Jones A.M., Dodd M.E., Webb A.K., Woodcock A. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax 2006 May, 61(5):425-429.
24. Widdicombe J., Singh V. Physiological and pathophysiological down-regulation of cough. Respir Physiol Neurobiol 2006, 150(2-3):105-117.
25. van der Giessen L., Loeve M., de Jongste J., Hop W., Tiddens H. Nocturnal cough in children with stable cystic fibrosis. Pediatr Pulmonol 2009, 44(9):859-865.
26. Weese-Mayer D.E., Kenny A.S., Bennett H.L., Ramirez J.M., Leurgans S.E. Familial dysautonomia: frequent, prolonged and severe hypoxemia during wakefulness and sleep. Pediatr Pulmonol 2008, 43(3):251-260. Erratum in: Pediatr Pulmonol 2008 Jun;43(6):624-5.
27. Kelsall A., Decalmer S., Webster D., Brown N., McGuinness K., Woodcock A. How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J 2008, 32(1):175-179.
28. Fontana G.A., Widdicombe J. What is cough and what should be measured?. Pulm Pharmacol Ther 2007, 20(4):307-312.
29. Marsden P.A., Smith J.A., Kelsall A.A., Owen E., Naylor J.R., Webster D., et al. A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol 2008, 122(5):903-907.
30. Wahl A.K., Rustøen T., Hanestad B.R., Gjengedal E., Moum T. Living with cystic fibrosis: impact on global quality of life. Heart Lung 2005, 34(5):324-331.
31. Stull D.E., Leidy N.K., Parasuraman B., Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin 2009, 25(4):929-942.
32. Pavesi L., Subburaj S., Porter-Shaw K. Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. Chest 2001, 120(4):1121-1128.
33. Temple R. Are surrogate markers adequate to assess cardiovascular disease drugs?. JAMA 1999, 282(8):790-795.